)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Abera Bioscience (ABERA) investor relations material
Abera Bioscience Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Achieved significant milestones in vaccine development, with preclinical and regulatory progress for pneumococcal and influenza candidates.
Secured financing through a fully subscribed directed share issue, raising up to 21.5 MSEK, and additional grants from CEPI and BactiVac.
Preparing for clinical phase 1 trials for the lead pneumococcal vaccine candidate, targeting study start in 2026.
Strengthened position in mucosal immunization and pandemic preparedness, with ongoing collaborations and proof-of-concept data.
Financial highlights
Q3 2025 operating income: 4,919 KSEK (up from 3,348 KSEK year-over-year), mainly from grants and currency gains.
Net loss after financial items for Q3: -835 KSEK (vs. -278 KSEK year-over-year); nine-month net loss: -1,656 KSEK (vs. -1,302 KSEK year-over-year).
Cash and bank at period end: 23,176 KSEK (vs. 3,105 KSEK year-over-year).
Equity at period end: 28,083 KSEK (vs. 8,524 KSEK year-over-year).
Cash flow from operations in Q3: -4,427 KSEK; total period cash flow: 15,229 KSEK.
Outlook and guidance
Financing secured for GMP production and phase 1 clinical studies of the pneumococcal vaccine.
Additional grant funding expected from CEPI and UK Vaccine Network through early 2026, supporting ongoing R&D.
Focus on advancing both pneumococcal and influenza vaccine programs to clinical phase in the coming year.
Ab-01.12: Human Challenge model impact
Influenza vaccine: clinical phase timeline?
How do clinical results drive partner interest?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Abera Bioscience earnings date
Q4 20259 Feb, 2026
Next Abera Bioscience earnings date
Q4 20259 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Abera Bioscience AB is a Sweden-based biotechnology company specializing in vaccine development. The company focuses on creating next-generation vaccines using its proprietary platform technology, which is designed to enhance immune response and target a wide range of diseases. The company is headquartered in Solna, Sweden, and its shares are listed on the Spotlight Stock Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage